舒筋颗粒治疗脑卒中后痉挛性偏瘫疗效观察

目的 观察舒筋颗粒治疗脑卒中后痉挛性偏瘫的疗效。方法 采用前瞻性随机双盲对照试验，将77例脑卒中伴偏瘫肢体肌张力增高的患者按1：1比例随机分为治疗1组(38例)和治疗2组(39例)，在常规治疗的基础上，治疗1组加用舒筋颗粒1号，治疗2组加用舒筋颗粒2号，疗程28d。治疗结束后，评定两组患者的疗效。结果 揭盲结果为治疗1组为治疗组，治疗2组为对照组。治疗组患者的肌张力改善情况、Fugel—Meyer评分和Barthel指数得分均优于对照组患者。结论 舒筋颗粒可改善偏瘫肢体的肌张力，从而促进患肢功能的恢复，进而改善患者的运动功能，提高其生活自理能力。

Effect of Shujinkeli on stroke patients with spastic hemiplegia

Objective To observe the effect of Shujinkeli on stroke patients with spastic hemiplegia. Methods The double blind test was applied in this study. 77 stroke patients with spastic hemiplegia were randomly divided into the group A (n=38) and the group B (n=39). Under the guidance of the criterion and routine treatment, patients of the group A were treated with Shujinkeli A and patients of the group B were treated with Shujinkeli B. After treatment, curative effect of patients was evaluated. Results The group A was the treatment group, and the group B was the control group. After treatment, the treatment group was superior to the control group in the improvement of muscular tension, Fugel-Meyer score and Barthel index. Conclusion The Shujinkeli can make the high muscular tension lower, which will accelerate the disabled limbs' recovery and improve patients' motor function and self-care ability of daily life.